Opus Genetics (IRD) Shares Outstanding (2010 - 2026)

Opus Genetics (IRD) has 17 years of Shares Outstanding data on file, last reported at $71.4 million in Q1 2026.

• Quarterly Shares Outstanding rose 56.98% year-over-year to $71.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.4 million (up 56.98% YoY) and the FY2025 annual result came in at $69.9 million, up 121.36% from the prior year.
• Shares Outstanding grew to $71.4 million in Q1 2026 per IRD's latest filing, from $69.9 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $71.4 million in Q1 2026 and bottomed at $19.2 million in Q1 2022.
• The 5-year median for Shares Outstanding is $25.1 million (2024), against an average of $34.7 million.
• The widest annual swing landed in 2023, when Shares Outstanding rose 4.41%; it then surged 146.37% in 2025.
• Tracing IRD's Shares Outstanding over 5 years: stood at $20.9 million in 2022, then climbed by 14.94% to $24.0 million in 2023, then surged by 31.68% to $31.6 million in 2024, then surged by 121.36% to $69.9 million in 2025, then advanced by 2.16% to $71.4 million in 2026.
• Per Business Quant, the three latest IRD Shares Outstanding figures stand at $71.4 million (Q1 2026), $69.9 million (Q4 2025), and $64.5 million (Q3 2025).

Peer Comparison